Product Description
Sorafenat - Sorafenib
Sorafenat contains sorafenib, which is a small molecular inhibitor of several tyrosine protein kinases.
Manufactured By:Natco Pharma Ltd.
Indication:Sorafenat is used for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer.
Available As:200 mg tablets. Bottle of 120 Tablets
Note:Sorafenat is a prescription drug and should be used under proper medical guidance and advice.
Request
Callback
Other Details:
- Item Code: 200mg
- Pay Mode Terms: L/C (Letter of Credit)
- Port of Dispatch: INDIA
- Packaging Details: 200MG BOTTLE OF 120 TABLETS